These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18813015)

  • 21. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid hormones and risk of breast cancer.
    Hulka BS; Liu ET; Lininger RA
    Cancer; 1994 Aug; 74(3 Suppl):1111-24. PubMed ID: 8039146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HRT and breast cancer: recent findings in the context of the evidence to date.
    Banks E; Canfell K; Reeves G
    Womens Health (Lond); 2008 Sep; 4(5):427-31. PubMed ID: 19072480
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progesterone+estrogen increased the risk of dementia in postmenopausal women. Surprising results of the WHIM study].
    Fried G
    Lakartidningen; 2003 Sep; 100(36):2742-3. PubMed ID: 14558187
    [No Abstract]   [Full Text] [Related]  

  • 26. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.
    Nelson HD; Walker M; Zakher B; Mitchell J
    Ann Intern Med; 2012 Jul; 157(2):104-13. PubMed ID: 22786830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
    Shapiro S
    Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 31. [Menopause in women--hormonal replacement therapy].
    Kulikowski M; Tomaszewska I
    Pol Tyg Lek; 1995 Nov; 50(44-47):5-9. PubMed ID: 8643429
    [No Abstract]   [Full Text] [Related]  

  • 32. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence.
    Barrett-Connor E
    Maturitas; 1996 Mar; 23(2):227-34. PubMed ID: 8735360
    [No Abstract]   [Full Text] [Related]  

  • 34. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
    Colditz GA
    J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.
    Perez MV; Wang PJ; Larson JC; Virnig BA; Cochrane B; Curb JD; Klein L; Manson JE; Martin LW; Robinson J; Wassertheil-Smoller S; Stefanick ML
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The history of hormone therapy use and recent controversy related to heart disease and breast cancer arising from prevention trial outcomes.
    Alexander IM
    J Midwifery Womens Health; 2012; 57(6):547-557. PubMed ID: 23217066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.